RPg Family Wealth Advisory’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-147
Closed -$11.1K 274
2017
Q4
$11.1K Sell
147
-27
-16% -$2.04K 0.01% 261
2017
Q3
$13.4K Buy
+174
New +$13.1K 0.01% 249
2017
Q1
Sell
-460
Closed -$30K 318
2016
Q4
$30K Sell
460
-47
-9% -$3.05K 0.03% 156
2016
Q3
$35.8K Buy
507
+182
+56% +$13.3K 0.03% 140
2016
Q2
$24K Buy
+325
New +$22.5K 0.01% 178

Other funds holding NVS

RPg Family Wealth Advisory's NVS Position: Q1 2018 in Review

RPg Family Wealth Advisory sold out of Novartis (NVS) in Q1 2018, closing a stake of 147 shares — an estimated $11.1K sold.

RPg Family Wealth Advisory first reported a position in NVS in Q2 2016 and held it in 5 quarters. The position peaked at $35.8K in Q3 2016. 1,012 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

  • RPg Family Wealth Advisory reported no remaining Novartis position as of Q1 2018 after selling out during the quarter.
  • RPg Family Wealth Advisory sold 147 Novartis shares in Q1 2018, an estimated $11.1K.
  • RPg Family Wealth Advisory first reported a position in Novartis in Q2 2016 and held it in 5 quarters.
  • RPg Family Wealth Advisory's Novartis position peaked at $35.8K in Q3 2016.
  • 1,012 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on RPg Family Wealth Advisory's 13F filing for Q1 2018, filed 15 May 2018.